35 results on '"S. Luzzago"'
Search Results
2. New size cut-off proposed by EAU Renal Cancer Working group better identifies patients who can benefit from local tumor ablation
3. Added value of MRI radiomics to predict pathological status of prostate cancer patients
4. The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses
5. Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence
6. Predicting the risk of biochemical recurrence at five years in patients treated with radical prostatectomy for prostate cancer: The PIPEN categories
7. Radio-guided surgery with DROP-IN beta probe for 68Ga-PSMA, in high-risk prostate cancer patients eligible for robotic-assisted radical prostatectomy
8. Three-dimensional prostate model use and augmented reality guided frozen section analysis during robot-assisted radical prostatectomy
9. Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
10. Effect of body mass index and obesity on perioperative and oncological outcomes in patients treated with thermal ablation for T1 renal cell tumors
11. Thermal ablation for small renal masses: identifying anthropometric predictors of surgical and oncologic outcomes
12. Three-dimensional prostate model use and augmented-reality guided frozen section analysis during robot-assisted radical prostatectomy
13. MO-0385 Added value of MRI radiomics to predict pathological status of prostate cancer patients
14. PO-1482 Estimation of inter-fraction motion of pelvic organs in SBRT treatments of prostate oligometastases
15. PO-1360 Nutritional and inflammatory status as predictive biomarkers in oligorecurrent PCa (RADIOSA TRIAL)
16. PD-0412 Impact of adjuvant radiotherapy on biochemical recurrence rates for pn1 prostate cancer patients
17. Differences in oncological outcomes and complication rates in patients treated with either radiofrequency or microwaves thermal ablation for T1 renal cell tumours
18. Perioperative and oncological outcomes in patients with a solitary kidney treated with thermal ablation for T1 renal cell tumour
19. Association between histology and oncological outcomes or complication rates in patients treated with thermal ablation for T1 renal cell tumours
20. Differences in oncological outcomes in patients treated with thermal ablation for T1 renal cell masses: complete ablation vs. partial ablation +/- immediate re-treatment
21. The effect of age on cancer-specific mortality in T1a stage renal cell carcinoma patients: a population-based study across all treatment’s modalities
22. Thermal ablation for small renal masses: identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes
23. Organ preserving surgery after glansectomy of partial penectomy in patients with recurrent penile cancer: oncological results
24. Perc-score as a nephrometry scoring system in percutaneous tumour ablation: comparison with renal, mrenal, padua and spare in a multi-centre series
25. Comparison of automated segmentation techniques for magnetic resonance images of the prostate
26. Validation of the recommended size cut-off for thermal ablation in T1 renal cell carcinoma patients, according to the EAU Guidelines
27. Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence according to risk stratification
28. Impact of postoperative radiotherapy on biochemical recurrence in pn1 prostate cancer patients: establishing the most appropriate timing for radiotherapy administration
29. Multiparametric magnetic resonance of the prostate during active surveillance for low-risk prostate cancer: Time to reduce the number of follow-up biopsies?
30. Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer
31. Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure?
32. First repeated biopsy represents the most informative predictor of progression-free survival at 3 years follow-up in patients included in an active surveillance protocol for low-risk prostate cancer
33. Impact of stage migration on bladder cancer: A slow but steady improvement in the long term survival rates after radical cystectomy in the last 25 years
34. 446 Salvage lymph node dissection for clinically recurrent prostate cancer: Which patients do benefit from this approach?
35. 456 Patterns of clinical recurrence and impact of site of metastasis on mortality of patients with node positive prostate cancer after radical prostatectomy and extended pelvic lymph node dissection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.